By Chris Taylor, Director, Viral Hepatitis, NASTAD
NASTAD Staff: Left to Right: Murray Penner, Deputy Director; Julie Scofield, Executive Director; Chris Taylor, Director, Viral Hepatitis
Last month, Julie Scofield, Executive Director of the National Alliance of State and Territorial AIDS Directors (NASTAD), was recognized by the White House Office of Drug Control Policy (ONDCP) and Office of National AIDS Policy (ONAP) for her leadership in the prevention and treatment of viral hepatitis. The event was held at the White House in observance World Hepatitis Day. NASTAD congratulates Julie Scofield and other colleagues recognized for their leadership to address the domestic and global viral hepatitis epidemics.
By Emily McCloskey, Manager, Policy and Legislative Affairs
Today, NASTAD released an infographic analyzing viral hepatitis funding. State health departments receive less than $1 dollar in federal funding for every person living with viral hepatitis for the Viral Hepatitis Prevention Coordinator (VHPC) program. The VHPC program is the only national program dedicated to the viral hepatitis epidemics and provides the only public health infrastructure for the prevention of viral hepatitis and linking individuals to care and treatment. In order to meet the goals established by the Viral Hepatitis Action Plan, the VHPC program must continue to be funded in all existing jurisdictions and increased resources are necessary to coordinate prevention efforts at the state and local levels. Continue reading
By Xavior Robinson, Senior Manager, Health Care Access, NASTAD
March 23 marked the fourth anniversary of the Affordable Care Act (ACA). While it is undeniable that the ACA’s inaugural open enrollment period has had its share of challenges, it is important to recognize that the movement to ensure that all Americans have equitable access to health care transcends the technology failures of HealthCare.gov. Over the past four years, state HIV/AIDS programs have worked to adapt and innovate to meet needs of people living with HIV and co-occurring conditions in our evolving health care landscape. Through the use of innovative solutions (see Raising the Bars), support from colleagues and staff, and an enduring commitment to the broader public health imperative presented by HIV, state AIDS directors have leveraged the ACA to achieve remarkable results, including: Continue reading
By Amanda Bowes, Associate, Health Care Access and Viral Hepatitis, NASTAD
Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released key findings of the 2014 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 19 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.
The Report provides an overview of the status of ADAPs as they prepared for full implementation of the Affordable Care Act (ACA). Continue reading
By Amy Killelea, Associate Director, Health Care Access, NASTAD
Insurers in two states – Blue Cross and Blue Shield in Louisiana and North Dakota – have prohibited the acceptance of premium payments from the Ryan White Program/AIDS Drug Assistance Program (ADAP) on behalf of eligible low-income clients. These policies risk leaving hundreds of low-income people living with HIV unable to access Qualified Health Plan coverage through the Affordable Care Act (ACA) and have prompted a swift federal and state advocacy response.